Transfused older stored red blood cells improve the clinical course and outcome in a canine lethal hemorrhage and reperfusion model

Transfusion

Volumn 55, Issue 11, 2015, Pages 2552-2563

  Solomon, Steven B ^a   Cortés Puch, Irene ^a   Sun, Junfeng ^a   Remy, Kenneth E ^a   Wang, Dong ^a   Feng, Jing ^a   Khan, Sameena S ^a,b   Sinchar, Derek ^c   Kim Shapiro, Daniel B ^d   Klein, Harvey G ^a   Natanson, Charles ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL FREE HEMOGLOBIN; HEMOGLOBIN; IRON; NITRIC OXIDE; NON TRANSFERRIN BOUND IRON; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEAGLE; BLEEDING; BLOOD TRANSFUSION REACTION; CANINE MODEL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; HEART OUTPUT; HEMOGLOBIN BLOOD LEVEL; INFLAMMATION; IRON BLOOD LEVEL; LIVER FRACTURE; LIVER INJURY; LUNG INJURY; MORTALITY; NONHUMAN; OLDER STORED ERYTHROCYTE TRANSFUSION; ORGAN INJURY; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; VASOCONSTRICTION; ANIMAL; BLOOD STORAGE; DOG; ERYTHROCYTE; HUMAN; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; SHOCK, HEMORRHAGIC;

ANIMALS; BLOOD PRESERVATION; DOGS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; RANDOM ALLOCATION; REPERFUSION INJURY; SHOCK, HEMORRHAGIC;

EID: 84947080285     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13213     Document Type: Article

References (44)

1. Global database on blood safety: report 2004-2005. Geneva: World Health Organization; 2008.
2. The 2011 National Blood Collection and Utilization Survey Report [Internet]. Rockville (MD): US Department of Health and Human Services; 2011 [cited 2015 Feb 20]. Available from: http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf
3. Wang D, Sun J, Solomon SB, et al., Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012; 52: 1184-95.
4. Solomon SB, Wang D, Sun J, et al., Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood 2013; 121: 1663-72.
5. Hod EA, Zhang N, Sokol SA, et al., Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010; 115: 4284-92.
6. Steiner ME, Ness PM, Assmann SF, et al., Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015; 372: 1419-29.
7. Lacroix J, Hebert PC, Fergusson DA, et al., Age of transfused blood in critically ill adults. N Engl J Med 2015; 372: 1410-8.
8. Fergusson DA, Hébert P, Hogan DL, et al., Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012; 308: 1443-51.
9. Heddle NM, Cook RJ, Arnold DM, et al., The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial. Transfusion 2012; 52: 1203-12.
10. Kaukonen KM, Bailey M, Ady B, et al., A randomised controlled trial of standard transfusion versus fresher red blood cell use in intensive care (TRANSFUSE): protocol and statistical analysis plan. Crit Care Resusc 2014; 16: 255-61.
11. Age of Blood in Children in Pediatric Intensive Care Units (ABC PICU) [Internet]. Bethesda (MD): ClinicalTrials.gov, U.S. National Institutes of Health; 2013 Aug 9 [cited 2015 Feb 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT01977547?term=age+of+blood+storage+red+cell&rank=1
12. Wang D, Cortés-Puch I, Sun J, et al., Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion 2014; 54: 1712-24.
13. Minneci PC, Deans KJ, Hansen B, et al., A canine model of septic shock: balancing animal welfare and scientific relevance. Am J Physiol Heart Circ Physiol 2007; 293: H2487-500.
14. Donadee C, Raat NJ, Kanias T, et al., Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-76.
15. Maas JJ, Pinsky MR, de Wilde RB, et al., Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. Crit Care Med 2013; 41: 143-50.
16. Bouglé A, Harrois A, Duranteau J., Resuscitative strategies in traumatic hemorrhagic shock. Ann Intensive Care 2013; 3: 1.
17. Peng CF, Murphy ML, Colwell K, et al., Controlled versus hyperemic flow during reperfusion of jeopardized ischemic myocardium. Am Heart J 1989; 117: 515-22.
18. Lee JH, Kim K, Jo YH, et al., Blood pressure-targeted stepwise resuscitation for hemorrhagic shock in rats. J Trauma Acute Care Surg 2014; 76: 771-8.
19. Shah KJ, Chiu WC, Scalea TM, et al., Detrimental effects of rapid fluid resuscitation on hepatocellular function and survival after hemorrhagic shock. Shock 2002; 18: 242-7.
20. Hori M, Kitakaze M, Sato H, et al., Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation 1991; 84: 2135-45.
21. Fiser SM, Kron IL, Long SM, et al., Controlled perfusion decreases reperfusion injury after high-flow reperfusion. J Heart Lung Transplant 2002; 21: 687-91.
22. Guan LY, Fu PY, Li PD, et al., Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide. World J Gastrointest Surg 2014; 6: 122-8.
23. Shimamura T, Zhu Y, Zhang S, et al., Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 1999; 188: 43-52.
24. Luo Y, Cha DG, Liu YL, et al., Differential effects of selective and non-selective nitric oxide synthase inhibitors on the blood perfusion of ischemia-reperfused myocardium in dogs. Med Sci Monit Basic Res 2013; 19: 181-6.
25. Serracino-Inglott F, Virlos IT, Habib NA, et al., Differential nitric oxide synthase expression during hepatic ischemia-reperfusion. Am J Surg 2003; 185: 589-95.
26. Thiemermann C, Szabõ C, Mitchell JA, et al., Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 1993; 90: 267-71.
27. Soliman MM., Effects of aminoguanidine, a potent nitric oxide synthase inhibitor, on myocardial and organ structure in a rat model of hemorrhagic shock. J Emerg Trauma Shock 2014; 7: 190-5.
28. Szabõ C, Billiar TR., Novel roles of nitric oxide in hemorrhagic shock. Shock 1999; 12: 1-9.
29. Cohen MV, Yang XM, Downey JM., Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 2006; 70: 231-9.
30. Reynolds JD, Bennett KM, Cina AJ, et al., S-nitrosylation therapy to improve oxygen delivery of banked blood. Proc Natl Acad Sci U S A 2013; 110: 11529-34.
31. Pacher P, Beckman JS, Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
32. Hod EA, Spitalnik SL., Harmful effects of transfusion of older stored red blood cells: iron and inflammation. Transfusion 2011; 51: 881-5.
33. Bullen JJ, Rogers HJ, Spalding PB, et al., Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol 2005; 43: 325-30.
34. Spitalnik SL., Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfusion 2014; 54: 2365-71.
35. Hod EA, Brittenham GM, Billote GB, et al., Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011; 118: 6675-82.
36. Natanson C, Kern SJ, Lurie P, et al., Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008; 299: 2304-12.
37. Sloan EP, Koenigsberg M, Gens D, et al., Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 1999; 282: 1857-64.
38. Kluger R., Red cell substitutes from hemoglobin-do we start all over again? Curr Opin Chem Biol 2010; 14: 538-43.
39. Baek JH, D'Agnillo F, Vallelian F, et al., Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest 2012; 122: 1444-58.
40. Matot I, Katz M, Pappo O, et al., Resuscitation with aged blood exacerbates liver injury in a hemorrhagic rat model. Crit Care Med 2013; 41: 842-9.
41. Lei C, Yu B, Shahid M, et al., Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock. Anesthesiology 2012; 117: 1190-202.
42. Baron DM, Beloiartsev A, Nakagawa A, et al., Adverse effects of hemorrhagic shock resuscitation with stored blood are ameliorated by inhaled nitric oxide in lambs. Crit Care Med 2013; 41: 2492-501.
43. Abadi U, Butenero G, Kogan T, et al., Prolonged blood storage does not effect survival in an animal model of hemorrhagic shock. Transfus Med Hemother 2011; 38: 272-6.
44. Hendrickson JE, Hod EA, Hudson KE, et al., Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells. Transfusion 2011; 51: 2695-702.